Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Gallbladder events rise modestly, especially with rapid loss. Less common signals include skin dysesthesia, which is now on the label, and a small thyroid-cancer association in two population studies with a tiny absolute event rate. Depression and suicidality remain unproven
Jump Back to Main Peptides List Sleep and Longevity Peptides for Women Women in perimenopause and menopause deserve to move comfortably throughout the day and get a solid nights sleepbut midlife symptoms like night sweats, achy joints, and simply feeling worn out often get in the way
Kidney function tests help evaluate clearance
Throw the packaging away separately to protect your privacy
What payers require for Zepbound prior authorization Zepbound PA requirements are typically more stringent: Documented BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity Evidence of lifestyle intervention including documented participation in diet, exercise, and behavioral modification programs (usually for at least 3 to 6 months) Prior medication trials (some plans require documented failure of other weight management medications before approving tirzepatide) Specialist involvement (some plans require referral to or management by a bariatric medicine specialist, endocrinologist, or obesity medicine physician) Ongoing weight monitoring documentation with specific weight loss targets (typically 5% of baseline weight within 3 to 6 months of starting therapy) Patients researching BMI requirements for GLP-1 medications should understand that these thresholds directly correspond to the prior authorization criteria their provider must document
